Gray-Zone Lymphoma — Trials

Gray-Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: David Bond, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02568553	Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma	completed	Phase 1	35	National Cancer Institute (NCI)NIH	1	Nov 26, 2025	clinicaltrials
NCT02996773	Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine	completed	Phase 1	50	University of ArizonaOTHER	1	Nov 10, 2025	clinicaltrials